Evidence map›Paper›PMID 22419778›Full record

ReviewEndocrine reviews2012

Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Laura N Vandenberg, Theo Colborn, Tyrone B Hayes, Jerrold J Heindel, David R Jacobs, Duk-Hee Lee, Toshi Shioda, Ana M Soto, Frederick S vom Saal, Wade V Welshons and 2 more

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Endocrine reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07560579 (Weight Loss and Endocrine Disrupting Chemicals), which is not on this map. Cited by 1,043 papers.

0numbers the graph read from it
0cells of the map it votes in
1,043citing papers in PubMed
160.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07560579 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2025 to 2026Enrolled226ConditionsObesity &Amp, Amp, Amp, OverweightArmsEducational curriculum, Weight loss Application, Urinary EDC metabolite testing, Siphox clinic biomarker test, Weight loss reporting
3 · Its place in the literature

Who cites it

1,043 citing papers in PubMed, 3,015 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Microplastics and Nanoplastics in Food: Dietary Toxicology Beyond Particle Counts.Comprehensive reviews in food science and food safety · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Associations of endocrine disrupting chemicals with anogenital distance across infancy.The Journal of clinical endocrinology and metabolism · 2026
    Observational
  15. Article
  16. Emerging trends in the global burden of colorectal cancer.Nature reviews. Clinical oncology · 2026
    Review
  17. Observational
  18. Article
  19. Review
  20. Review

983 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Laura N VandenbergTufts University, Center for Regenerative and Developmental Biology, Department of Biology, 200 Boston Avenue, Suite 4600, Medford, Massachusetts 02155, USA. laura.vandenberg@tufts.edu
Theo Colborn
Tyrone B Hayes
Jerrold J Heindel
David R Jacobs
Duk-Hee Lee
Toshi Shioda
Ana M Soto
Frederick S vom Saal
Wade V Welshons
R Thomas Zoeller
John Peterson Myers
Tufts University · USUniversity of Missouri · USCenter for Cancer Research · USKyungpook National University · KRNational Institute of Environmental Health Sciences · UST1D Exchange · USUniversity of California, Berkeley · USUniversity of Massachusetts Amherst · USUniversity of Minnesota · US

Funding

EPIDEMIOLOGY: OXIDATIVE STRESS AND EARLY ATHEROSCLEROSISR01HL053560 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI GROSS, MYRON D, JACOBS, DAVID R · 1995 to 2014
$9.0M
Mechanisms of developmental toxicity of Bisphenol-AR01ES008314 · NIEHS · TUFTS UNIVERSITY BOSTON · PI SOTO, ANA · 1996 to 2016
$6.8M
PCB Disruption of Thyroid Hormone Action During DevelopmentR01ES010026 · NIEHS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ZOELLER, ROBERT THOMAS · 2000 to 2013
$3.8M
Bisphenol A: Urine flow disorder and prostate pathologyRC2ES018764 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI RICKE, WILLIAM A, VOM SAAL, FREDERICK S · 2009 to 2010
$1.1M
Epidemiology: Oxidative Stress and Early AtherosclerosisR56HL053560 · NHLBI · UNIVERSITY OF MINNESOTA · PI JACOBS, DAVID R · 2009 to 2009
$494k
PCB Disruption of Thyroid Hormone Action during DevelopmentR56ES010026 · NIEHS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI ZOELLER, ROBERT THOMAS · 2007 to 2007
$387k
Bioelectrical controls of left-right asymmetryF32GM087107 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI VANDENBERG, LAURA N. · 2009 to 2010
$98k
NHLBI NIH HHS HL 53560NHLBI NIH HHS R01 HL053560NHLBI NIH HHS R56 HL053560NIEHS NIH HHS ES 010026NIEHS NIH HHS ES018764NIEHS NIH HHS ES 08314NIEHS NIH HHS R01 ES008314NIEHS NIH HHS R01 ES010026NIEHS NIH HHS R56 ES010026NIEHS NIH HHS RC2 ES018764NIGMS NIH HHS F32 GM087107NIGMS NIH HHS GM 087107
6 · The paper itself

Abstract

For decades, studies of endocrine-disrupting chemicals (EDCs) have challenged traditional concepts in toxicology, in particular the dogma of "the dose makes the poison," because EDCs can have effects at low doses that are not predicted by effects at higher doses. Here, we review two major concepts in EDC studies: low dose and nonmonotonicity. Low-dose effects were defined by the National Toxicology Program as those that occur in the range of human exposures or effects observed at doses below those used for traditional toxicological studies. We review the mechanistic data for low-dose effects and use a weight-of-evidence approach to analyze five examples from the EDC literature. Additionally, we explore nonmonotonic dose-response curves, defined as a nonlinear relationship between dose and effect where the slope of the curve changes sign somewhere within the range of doses examined. We provide a detailed discussion of the mechanisms responsible for generating these phenomena, plus hundreds of examples from the cell culture, animal, and epidemiology literature. We illustrate that nonmonotonic responses and low-dose effects are remarkably common in studies of natural hormones and EDCs. Whether low doses of EDCs influence certain human disorders is no longer conjecture, because epidemiological studies show that environmental exposures to EDCs are associated with human diseases and disabilities. We conclude that when nonmonotonic dose-response curves occur, the effects of low doses cannot be predicted by the effects observed at high doses. Thus, fundamental changes in chemical testing and safety determination are needed to protect human health.

Indexed as

AmphibiansAnimalsAnimals, WildAtrazineBenzhydryl CompoundsBisphenol A CompoundsBreastDioxinsDose-Response Relationship, DrugEndocrine DisruptorsEnvironmental ExposureFemaleHerbicidesHumansMalePerchloratesAtrazineBenzhydryl Compoundsbisphenol ABisphenol A CompoundsDioxinsEndocrine DisruptorsHerbicidesperchloratePerchloratesPhenols

Identifiers

PMID22419778
PMCPMC3365860
OpenAlexW2097327668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.